STAT
MARCH 26, 2025
On a recent Friday evening, it struck me: I needed to speak to a neurosurgeon. I was watching someone root around in actor Adam Scott’s head on an episode from the second season of “Severance” on Apple TV+. (Note: This post and podcast episode contain spoilers for “Severance.” You’ve been warned.) I needed to know: How realistic is the brain surgery that gives the show its name and premise?
European Pharmaceutical Review
MARCH 26, 2025
The US Food and Drug Administration (FDA) has approved Blujepa ( gepotidacin ) antibiotic for uncomplicated urinary tract infections (uUTIs) in female adults and paediatric patients aged 12 years old and over. The first-in-class bactericidal drug is indicated for such infections caused by E scherichia coli, Klebsiella pneumoniae, Citrobacter freundii complex, Staphylococcus saprophyticus and Enterococcus faecalis.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
MARCH 26, 2025
In recent months, a new kind of partnership between telehealth companies and pharmaceutical manufacturers has come under scrutiny over concerns that such arrangements could lead to inappropriate prescriptions and poor care. Eli Lilly and Pfizer, along with five telehealth companies accessible through the pharma companies’ websites, have recently received letters from four senators echoing those concerns, asking questions about care, prescription volume, and the flow of data and money betw
The Pharmacist
MARCH 26, 2025
Members of the Royal Pharmaceutical Society (RPS) have voted in favour of proposed changes that will see it become a Royal College. A third of RPS members turned out to vote, at 6,144 voters from a total of 19,594 eligible. Of those, 71.1% (4,369 members) voted to confirm the proposed changes to the RPS's Royal […] The post RPS to become Royal College of Pharmacy after member vote appeared first on The Pharmacist.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
STAT
MARCH 26, 2025
Y ou’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every Wednesday. My colleague Casey Ross has been reporting on AI in health care since before it was cool (remember IBM’s Watson ?
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
STAT
MARCH 26, 2025
You’re reading The MAHA Diagnosis , a STAT series that examines the major elements of the Make America Healthy Again movement led by Robert F. Kennedy Jr. From cancer warning labels to soda taxes , progressive states like California and New York have long led the way on legislation meant to improve public health. Now the Make America Healthy Again movement is prompting lawmakers in more conservative states, like Texas, Florida, Oklahoma, and Utah, to join blue ones in introducing bills th
PharmaVoice
MARCH 26, 2025
A delay of the prescription-to-OTC rule signals health agencies’ ongoing reluctance to implement new regulations.
Express Pharma
MARCH 26, 2025
AdjuTec Pharma AS, a privately held company developing antibiotic resistance breakers, announces that it has entered into a research collaboration agreement with Venus Remedies. Venus Remedies will perform a pre-clinical evaluation of AdjuTec Pharmas APC-148 platform technology. AdjuTec Pharma has developed novel inhibitor technologies that selectively destroy antibiotic resistance mechanisms in multidrug-resistant bacteria, thereby restoring the effectiveness of commercially available antibioti
BioPharma Dive
MARCH 26, 2025
Clearance of Vykat unlocks what analysts anticipate will be a lucrative market opportunity for Soleno Therapeutics.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharma Marketing Network
MARCH 26, 2025
Artificial intelligence (AI) is no longer a futuristic concept in healthcareits here, embedded in nearly every touchpoint of modern pharma marketing. From generative AI tools that draft emails to predictive algorithms that segment target audiences, the speed and scale of innovation are staggering. But as pharma marketers race to adopt these tools, a central question looms: Is AI fueling smarter engagement, or setting the stage for a compliance disaster?
The Pharmacist
MARCH 26, 2025
Pharmacy minister Stephen Kinnock has called the National Pharmacy Association (NPA)'s proposed collective action 'premature, unnecessary and detrimental to community pharmacy patients'. And he urged the NPA to 'reconsider its position' and wait for the outcome of funding negotiations with Community Pharmacy England (CPE). Mr Kinnock added that the negotiations had been 'constructive' and 'will […] The post Pharmacy minister calls NPA action 'premature and unnecessary' appeared f
Pharmafile
MARCH 26, 2025
Cold Chain Technologies (CCT), a global provider for temperature-sensitive packing and digital solutions, has acquired Global Cold Chain Solutions (GCCS), a provider of passive cold chain solutions primarily in Australia and India. Based in Massachusetts, US, the deal furthers CCT’s reach to South Asia and Oceania, where there is vast investment in life sciences verticals. […] The post Cold Chain Technologies acquires Global Cold Chain Solutions appeared first on Pharmafile.
Drug Patent Watch
MARCH 26, 2025
The Unseen Hurdles of Generic Drug Development: Lessons Learned As the pharmaceutical industry continues to evolve, one thing remains constant: the pursuit of affordable, high-quality medications for patients worldwide. Generic drugs have long been a vital part of this equation, offering a more accessible alternative to brand-name medications. However, the journey to bringing a generic drug to market is often fraught with challenges.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Pharmafile
MARCH 26, 2025
Coronado Research, a UK-based consultancy-led organisation, has announced that it has appointed Gary Lyons as executive vice president (EVP) for medical affairs. Lyons is a medical affairs leader, with experience in senior positions in pharmaceutical, consultancy and agency sectors. He has worked on developing medical communication services locally and globally.
Pharma Times
MARCH 26, 2025
NOUS-209 shows potential to intercept cancer in its early stages
Pharmafile
MARCH 26, 2025
Allegro has announced that hydrocelin, its injectable microparticle hydrogel, showed no signs of toxicity in two preclinical studies. Allegro is a biomedical company that develops nanotechnology-based treatments for degenerative joint disease. The preclinical studies were conducted in rats for periods of four and 13 weeks, respectively. Hydrocelin was injected into four separate locations, and a […] The post Allegro shares promising preclinical results for osteoarthritis treatment appeared
BioPharma Dive
MARCH 26, 2025
The company plans to file next year for an accelerated clearance of its "exon-skipping" treatment, which would compete with one of Sarepta's medicines.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Pharmafile
MARCH 26, 2025
Pharming Group has announced that the first patient has been dosed in a phase 2 clinical trial evaluating leniolisib in common variable immunodeficiency (CVID) patients with immune dysregulation. The company, based in Leiden, the Netherlands, specialises in developing and commercialising medicines for patients with rare, debilitating and life threatening diseases.
pharmaphorum
MARCH 26, 2025
Recent financings in the biotech space include rounds for Character Bio, Tempero, Epicrispr, Hillstar Bio, and Ampersand Biomedicines
BioPharma Dive
MARCH 26, 2025
The Johns Hopkins surgeon will helm the agency as layoffs loom and important decisions on treatments for rare and infectious diseases await.
The Pharmacist
MARCH 26, 2025
The new GP contract for 2025/26 will see changes to the Additional Roles Reimbursement Scheme (ARRS) and Quality and Outcomes Framework (QOF). While the full GP contract and primary care network (PCN) contract are yet to be published, some information has already been shared by NHS England and the British Medical Association (BMA). The Pharmacistbreaks […] The post New GP contract: What PCN pharmacists need to know appeared first on The Pharmacist.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Drug Channels
MARCH 26, 2025
Spring has officially arrived in sunny downtown Philadelphiathe proud home base of Drug Channels. As you can see on the right, we celebrated in Miami at the Drug Channels Leadership Forum. The vernal equinox also brought a surprising surge of industry updates and noteworthy news you wont want to miss: Blue Shield of California provides a puzzling update to its PBM unbundling effort The Stelara biosimilar price war begins My reaction to Optum Rxs pharmacy reimbursement announcement A valuable Fol
Pharmaceutical Technology
MARCH 26, 2025
Sanofi will commence a Phase I/II trial with its vaccine candidate in the next few days to start generating immunogenicity data.
pharmaphorum
MARCH 26, 2025
The UK is providing 2m in funding to allow digital assessment to be added to a highly-anticipated trial of blood tests for diagnosing dementia
BioPharma Dive
MARCH 26, 2025
The startup is using CRISPR tools to stop errant expression of a gene linked to facioscapulohumeral muscular dystrophy, a disorder on the radars of several drugmakers.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Express Pharma
MARCH 26, 2025
Japans Ministry of Health, Labor, and Welfare (MHLW) announced a new 10-year government fund in January 2025 to support innovative drug development. The initiative signals a stronger push towards pro-innovation policies, aiming to strengthen drug discovery capabilities and build a more resilient pharmaceutical ecosystem in the country, says GlobalData.
BioPharma Dive
MARCH 26, 2025
The German firm licensed a PRMT5 inhibitor that’s now in Phase 1 testing. Elsewhere, GSK is testing an intriguing hypothesis and Novo fine tuned its Wegovy cash-pay program.
Pharmaceutical Commerce
MARCH 26, 2025
Jen Butler, chief commercial officer, Pleio, discusses how the companys GoodStart programs help patients navigate specialty pharmacies.
Expert insights. Personalized for you.
215 
Let's personalize your content